# OnCo record transcenta (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/transcenta/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "transcenta" ;
  schema:name "Transcenta"@en ;
  schema:alternateName "Transcenta Holding"@en, "Suzhou Transcenta Therapeutics"@en, "创胜集团"@en, "HKEX:6628"@en ;
  schema:description "Transcenta is a Suzhou antibody company whose Claudin 18.2 antibody osemitamab (TST001) is being tested with nivolumab and chemotherapy as first-line treatment for stomach cancer."@en ;
  schema:url <https://onco.cc/companies/transcenta/>, <https://www.transcenta.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.transcenta.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "CN" ;
  onco:drugs <https://onco.cc/drugs/tst001/>, <https://onco.cc/drugs/tst003/> .